|
1
|
Darwin Global Management
St. Helier,
Jersey
|
$456M
|
+$5M
|
+29,708
|
+1%
|
|
|
2
|
Paradigm Biocapital Advisors
New York
|
$178M
|
+$187M
|
+1,114,784
|
New
|
|
|
3
|
UBS Group
Zurich,
Switzerland
|
$123M
|
+$108M
|
+639,607
|
+497%
|
|
|
4
|
|
$114M
|
–
|
–
|
–
|
|
|
5
|
Millennium Management
New York
|
$90.9M
|
+$1.88M
|
+11,206
|
+2%
|
|
|
6
|
Holocene Advisors
New York
|
$78.8M
|
+$69M
|
+410,428
|
+488%
|
|
|
7
|
Eventide Asset Management
Boston,
Massachusetts
|
$57M
|
-$4.28M
|
-25,441
|
-7%
|
|
|
8
|
Deerfield Management
New York
|
$48.5M
|
+$11.8M
|
+70,200
|
+30%
|
|
|
9
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$44.9M
|
+$47.4M
|
+281,805
|
New
|
|
|
10
|
|
$32.1M
|
+$29.2M
|
+173,396
|
+619%
|
|
|
11
|
Perceptive Advisors
New York
|
$24.2M
|
-$44.1M
|
-262,260
|
-63%
|
|
|
12
|
Patient Square Capital
Menlo Park,
California
|
$18.6M
|
+$19.6M
|
+116,684
|
New
|
|
|
13
|
Duquesne Family Office
New York
|
$16.9M
|
+$17.8M
|
+106,100
|
New
|
|
|
14
|
|
$16.8M
|
+$10.2M
|
+60,910
|
+137%
|
|
|
15
|
MPM BioImpact
Boston,
Massachusetts
|
$14M
|
+$47.9K
|
+285
|
+0.3%
|
|
|
16
|
Affinity Asset Advisors
New York
|
$10.4M
|
+$7.57M
|
+45,000
|
+225%
|
|
|
17
|
Fred Alger Management
New York
|
$9.98M
|
-$2.83M
|
-16,820
|
-21%
|
|
|
18
|
PFM Health Sciences
San Francisco,
California
|
$9.48M
|
+$6.66M
|
+39,609
|
+200%
|
|
|
19
|
Renaissance Technologies
New York
|
$8.29M
|
+$8.74M
|
+52,000
|
New
|
|
|
20
|
Longaeva Partners
Chicago,
Illinois
|
$5.34M
|
+$5.63M
|
+33,492
|
New
|
|
|
21
|
TD Asset Management
Toronto,
Ontario, Canada
|
$5.33M
|
+$5.62M
|
+33,410
|
New
|
|
|
22
|
BNP Paribas Financial Markets
Paris,
France
|
$5.19M
|
+$5.06M
|
+30,077
|
+1,229%
|
|
|
23
|
ADAR1 Capital Management
Austin,
Texas
|
$4.29M
|
-$2.18M
|
-12,959
|
-33%
|
|
|
24
|
Artia Global Partners
Miami,
Florida
|
$3.98M
|
+$1.18M
|
+7,000
|
+39%
|
|
|
25
|
Quadrature Capital
London,
United Kingdom
|
$3.78M
|
-$189K
|
-1,124
|
-5%
|
|
